DONEGAL MUTUAL INSURANCE CO purchased $377K of DGICA

DONEGAL MUTUAL INSURANCE CO purchased 20,000 shares of DONEGAL GROUP INC (DGICA) at an average of $18.87 ($18.68–$19.06, $0.38M total) across 2 trades over 2026-08-21 to 2026-08-24.

Original reporting
SEC EDGAR · DONEGAL MUTUAL INSURANCE CO
Published Aug 25, 2026, 1:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 2:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DGICA
Neutral
high confidence
Mentioned
$DGICA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DGICANeutralLow
01

Why it matters

The purchase is a routine insider transaction with limited market impact.

02

Market read

Low relevance; modest insider purchase unlikely to affect price.

03

What to watch

Potential upcoming corporate actions not disclosed; insider may be positioning for future events.

Relevance 5/10Novelty 3/10Timing: filed today

Background

Form 4 filings disclose insider transactions; Donegal Mutual Insurance Co is a 10% owner of Donegal Group Inc.

Company-level read

Ticker impact

$DGICANeutralHigh confidence
Context

Donegal Mutual Insurance Co purchased 20,000 shares of Donegal Group Inc for $377,404, disclosed via a Form 4 filing.

Expected impact

Minimal impact; price likely unchanged.

Evidence & confidence

The transaction size is modest relative to market cap and represents a routine insider buy.

Market effects

None; transaction is company‑specific.

None; limited to Donegal Group Inc.

None

Counterpoint

Even small insider buys can signal confidence; monitor for follow‑on purchases.

Key entities

  • Donegal Mutual Insurance Co

    Purchaser of 20,000 shares.

  • Donegal Group Inc

    Issuer of the shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DGICAMed

Donegal Group Inc (DGICA) Q3 2026 Earnings Call Highlights: Ninth Straight Profitable

Donegal Group (DGICA) reported Q3 2026 earnings, highlighting a 9th straight profitable quarter. CEO Kevin Burke discussed cloud migration timelines and AI integration. Commercial lines saw a 3.2% rise in core loss ratio due to workers' comp and liability losses. Personal lines improved with a 5.4% decline in net premiums written and a 146% increase in new business. Weather-related losses were $19.1M, and investment income rose 5% to $14.7M.

$DGICAMed

Donegal Group Q3 2026 slides: profitability holds amid soft market

Donegal Group Inc. (DGICA) reported Q3 2026 earnings with adjusted EPS of $0.50, beating estimates, but revenue of $209.7M missed forecasts. Underwriting profitability persisted with a combined ratio of 96.5%, though premiums declined. The stock rose 2.07% premarket. Management highlighted strategic initiatives and conservative investment strategies amid soft market conditions.

$DGICAMed

Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results

DONEGAL GROUP INC (DGICA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results MARIETTA, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the third quarter and first nine months o